Alectinib in crizotinib-refractory alk-rearranged non-small-cell lung cancer: A phase II global study
- Sai Hong Ignatius Ou
- , Jin Seok Ahn
- , Luigi De Petris
- , Ramaswamy Govindan
- , James Chih Hsin Yang
- , Brett Hughes
- , Hervé Lena
- , Denis Moro-Sibilot
- , Alessandra Bearz
- , Santiago Viteri Ramirez
- , Tarek Mekhail
- , Alexander Spira
- , Walter Bordogna
- , Bogdana Balas
- , Peter N. Morcos
- , Annabelle Monnet
- , Ali Zeaiter
- , Dong Wan Kim
- University of California at Irvine
- Karolinska Institutet
- Washington University St. Louis
- National Taiwan University
- University of Queensland
- CHU de Rennes
- CHU de Grenoble
- IRCCS Centro di Riferimento Oncologico - Aviano PN
- USP Institut Universitari Dexeus
- AdventHealth Orlando
- Virginia Cancer Specialists
- F. Hoffmann-La Roche AG
- Seoul National University
Research output: Contribution to journal › Article › peer-review
576
Link opens in a new tab
Scopus
citations